Monika Sharma

Ahmedabad, GJ 382355, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Chronic DSS-Induced Colitis Exacerbates Parkinson's Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure.

Chronic DSS-Induced Colitis Exacerbates Parkinson's Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure.

Journal: ACS pharmacology & translational science

Published: May 16, 2024

Correction: Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Correction: Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Journal: Molecular neurobiology

Published: October 14, 2022

Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.

Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.

Journal: Neurochemical research

Published: September 07, 2022

Association of COVID-19 with Comorbidities: An Update.

Association of COVID-19 with Comorbidities: An Update.

Journal: ACS pharmacology & translational science

Published: September 07, 2022

AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.

AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.

Journal: Metabolic brain disease

Published: July 12, 2022

Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation.

Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation.

Journal: ACS pharmacology & translational science

Published: June 23, 2022

Correction to: Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.

Correction to: Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.

Journal: Neurotoxicity research

Published: April 26, 2022

Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Journal: Molecular neurobiology

Published: April 04, 2022

Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.

Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.

Journal: Neurotoxicity research

Published: April 06, 2021

Correction to: Kinesins: Motor Proteins as Novel Target for the Treatment of Chronic Pain.

Correction to: Kinesins: Motor Proteins as Novel Target for the Treatment of Chronic Pain.

Journal: Molecular neurobiology

Published: September 04, 2020

Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.

Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.

Journal: Neuroscience letters

Published: November 20, 2019

A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.

A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.

Journal: ACS chemical neuroscience

Published: August 07, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026